These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36670276)

  • 21. Potential of a new MRI for visualizing cerebellar involvement in progressive supranuclear palsy.
    Hara K; Watanabe H; Ito M; Tsuboi T; Watanabe H; Nakamura R; Senda J; Atsuta N; Adachi H; Aiba I; Naganawa S; Sobue G
    Parkinsonism Relat Disord; 2014 Feb; 20(2):157-61. PubMed ID: 24172606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSP.
    Mangesius S; Hussl A; Krismer F; Mahlknecht P; Reiter E; Tagwercher S; Djamshidian A; Schocke M; Esterhammer R; Wenning G; Müller C; Scherfler C; Gizewski ER; Poewe W; Seppi K
    Parkinsonism Relat Disord; 2018 Jan; 46():47-55. PubMed ID: 29126761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance parkinsonism index in progressive supranuclear palsy and vascular parkinsonism.
    Mostile G; Nicoletti A; Cicero CE; Cavallaro T; Bruno E; Dibilio V; Luca A; Sciacca G; Raciti L; Contrafatto D; Chiaramonte I; Zappia M
    Neurol Sci; 2016 Apr; 37(4):591-5. PubMed ID: 26820655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Manual MRI morphometry in Parkinsonian syndromes.
    Möller L; Kassubek J; Südmeyer M; Hilker R; Hattingen E; Egger K; Amtage F; Pinkhardt EH; Respondek G; Stamelou M; Möller F; Schnitzler A; Oertel WH; Knake S; Huppertz HJ; Höglinger GU
    Mov Disord; 2017 May; 32(5):778-782. PubMed ID: 28150443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Midbrain MRI assessments in progressive supranuclear palsy subtypes.
    Picillo M; Tepedino MF; Abate F; Erro R; Ponticorvo S; Tartaglione S; Volpe G; Frosini D; Cecchi P; Cosottini M; Ceravolo R; Esposito F; Pellecchia MT; Barone P; Manara R
    J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):98-103. PubMed ID: 31527182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The utility of quantitative MRI parameters in discriminating progressive supranuclear palsy from Parkinson's disease.
    Onder H; Kocer BG; Turan A; Comoglu S
    Neurol Res; 2023 Aug; 45(8):738-744. PubMed ID: 37068211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Automated brainstem volumetry can aid in the diagnostics of parkinsonian disorders.
    Sjöström H; Granberg T; Hashim F; Westman E; Svenningsson P
    Parkinsonism Relat Disord; 2020 Oct; 79():18-25. PubMed ID: 32858488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deep Learning-based Approach for Brainstem and Ventricular MR Planimetry: Application in Patients with Progressive Supranuclear Palsy.
    Nigro S; Filardi M; Tafuri B; Nicolardi M; De Blasi R; Giugno A; Gnoni V; Milella G; Urso D; Zoccolella S; Logroscino G; ; ;
    Radiol Artif Intell; 2024 May; 6(3):e230151. PubMed ID: 38506619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combining quantitative susceptibility mapping to the morphometric index in differentiating between progressive supranuclear palsy and Parkinson's disease.
    Azuma M; Hirai T; Nakaura T; Kitajima M; Yamashita S; Hashimoto M; Yamada K; Uetani H; Yamashita Y; Wang Y
    J Neurol Sci; 2019 Nov; 406():116443. PubMed ID: 31634718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological features of progressive supranuclear palsy with asymmetrical atrophy of the superior cerebellar peduncle.
    Koizumi R; Akagi A; Riku Y; Sone J; Miyahara H; Tanaka F; Yoshida M; Iwasaki Y
    Neuropathology; 2023 Jun; 43(3):233-243. PubMed ID: 36222051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3.0-T MR imaging.
    Tsukamoto K; Matsusue E; Kanasaki Y; Kakite S; Fujii S; Kaminou T; Ogawa T
    Neuroradiology; 2012 Sep; 54(9):947-55. PubMed ID: 22274571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MR findings in the substantia nigra on phase difference enhanced imaging in neurodegenerative parkinsonism.
    Sugiyama A; Sato N; Kimura Y; Ota M; Maekawa T; Sone D; Enokizono M; Murata M; Matsuda H; Kuwabara S
    Parkinsonism Relat Disord; 2018 Mar; 48():10-16. PubMed ID: 29279191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of the superior cerebellar peduncle for differential diagnosis of progressive supranuclear palsy: A meta-analysis.
    Sako W; Murakami N; Izumi Y; Kaji R
    J Neurol Sci; 2017 Jul; 378():153-157. PubMed ID: 28566154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Midbrain area for differentiating Parkinson's disease from progressive supranuclear palsy.
    Ghourchian S; Mousavi A; Zamani B; Shahidi G; Rohani M
    Clin Neurol Neurosurg; 2019 Aug; 183():105383. PubMed ID: 31181432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accuracy of magnetic resonance parkinsonism index for differentiation of progressive supranuclear palsy from probable or possible Parkinson disease.
    Morelli M; Arabia G; Salsone M; Novellino F; Giofrè L; Paletta R; Messina D; Nicoletti G; Condino F; Gallo O; Lanza P; Quattrone A
    Mov Disord; 2011 Feb; 26(3):527-33. PubMed ID: 21287599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brainstem Biomarkers of Clinical Variant and Pathology in Progressive Supranuclear Palsy.
    Grijalva RM; Pham NTT; Huang Q; Martin PR; Ali F; Clark HM; Duffy JR; Utianski RL; Botha H; Machulda MM; Weigand SD; Ahlskog JE; Dickson DW; Josephs KA; Whitwell JL
    Mov Disord; 2022 Apr; 37(4):702-712. PubMed ID: 34970796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accuracy of Magnetic Resonance Parkinsonism Index in Differentiating Progressive Supranuclear Palsy from Parkinson's Disease among South Indian Population: A Retrospective Case Control Study.
    Janarthanan V; Nadhamuni K; Rajakumar S; Padmanaban E; Amirthalingam U; Achantani Y
    Indian J Radiol Imaging; 2021 Jul; 31(3):596-600. PubMed ID: 34790303
    [No Abstract]   [Full Text] [Related]  

  • 38. Diagnostic validity of magnetic resonance parkinsonism index in differentiating patients with progressive supranuclear palsy from patients with Parkinson's disease.
    Zhang K; Liang Z; Wang C; Zhang X; Yu B; Liu X
    Parkinsonism Relat Disord; 2019 Sep; 66():176-181. PubMed ID: 31420309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic Resonance Imaging and Neurofilament Light in the Differentiation of Parkinsonism.
    Archer DB; Mitchell T; Burciu RG; Yang J; Nigro S; Quattrone A; Quattrone A; Jeromin A; McFarland NR; Okun MS; Vaillancourt DE
    Mov Disord; 2020 Aug; 35(8):1388-1395. PubMed ID: 32357259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations.
    Paviour DC; Price SL; Jahanshahi M; Lees AJ; Fox NC
    Mov Disord; 2006 Jul; 21(7):989-96. PubMed ID: 16602104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.